Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT1040190111
JPRN-jRCT1040190111
Recruiting
N/A

Changes in bone mineral density and serum calcium levels after romosozumab treatmet in postmenopausal osteoporosis patients:About short-term results at 6 months

Kobayakawa Tomonori0 sites60 target enrollmentJanuary 31, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Kobayakawa Tomonori
Enrollment
60
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 31, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Kobayakawa Tomonori

Eligibility Criteria

Inclusion Criteria

  • •1\.postmenopausal women with osteoporosis
  • •2\.patients who used romosozumab for 6 months

Exclusion Criteria

  • •1\.patients who are allergic to romosozumab
  • •2\.hypocacemia

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
A prospective study of bone mineral density changes in patients during perioperative chemotherapy for breast cancerBreast cancer
JPRN-UMIN000053265Hyogo Prefectural Harima Himeji General Medical Center50
Completed
N/A
Effect on bone turnover and Bone Mineral Density (BMD) of low dose oral silicon as an adjunct to calcium/vitamin D3 in a randomised, placebo-controlled trial
ISRCTN57103074Bio Minerals N.V. (Belgium)184
Active, Not Recruiting
Phase 1
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.
EUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46
Completed
N/A
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting antibody
ISRCTN82317088South Tees Hospitals NHS Foundation Trust (UK)46
Completed
N/A
The Effect on Behavior and Bone Mineral Density of Individualized Bone Mineral Density Feedback and Educational Interventions in Premenopausal Women: a Randomized Controlled Trial.
ACTRN12605000139673niversity of Tasmania400